Press Releases

---------------------------------------------------------------- FOR IMMEDIATE RELEASE

CONTACTS:	César García, Chairman and Chief Executive Officer
	818-709-1244
	-or-
	Ron Stabiner, The Wall Street Group, Inc.
	212-888-4848

IRIS TO PRESENT AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE AUGUST 13, 2008

CHATSWORTH, CA, Aug. 6, 2008 - IRIS INTERNATIONAL, INC. (NASDAQ: IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chairman, President and Chief Executive Officer César García will present an overview of the Company at the Canaccord Adams 28th Annual Global Growth Conference at 2:30 p.m. Eastern time on Wednesday, August 13, 2008 at the Intercontinental Hotel in Boston, Mass.

Canaccord Adams hosts global events with a global perspective, bringing institutions and issuers together with world-class ideas and investment opportunities. These robust and objective meetings are designed to advance knowledge and build relationships in our areas of expertise - Mining and Metals, Energy, Life Sciences, Technology, Consumer, Real Estate and Industrial Growth.

ABOUT IRIS INTERNATIONAL
IRIS International is a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. Our products leverage our strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories. The initial applications for our technology have been in the urinalysis market and we are the leading worldwide provider of urine microscopy systems, with an installed based of more than 1,900 systems in over 50 countries.